{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T06:22:04Z","timestamp":1788070924371,"version":"build-2784847793"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:p>The objective was to evaluate whether routine aspirin 75 mg is more cost-effective than the Fetal Medicine Foundation screen-and-treat approach for preeclampsia prevention in low-risk nulliparous women. A health economic decision analytical model was devised to estimate the discounted net health and cost outcomes of routine aspirin versus Fetal Medicine Foundation screening test\u2013indicated aspirin for a cohort of 100\u2009000 low-risk nulliparous women. Both strategies were compared with no intervention. A subanalysis also compared disaggregated components of the algorithm. The analysis used data from hospital administration, literature, and a randomized controlled trial. Sensitivity analyses assessed the impact of aspirin adherence, test cost, and accuracy on study results. Presumed rates of preeclampsia were 3.75% with no intervention versus 0.45% with aspirin use. Results found that routine aspirin was the preferred strategy, in terms of greater health gains and larger cost savings. It provided 163 quality-adjusted life-years relative to no intervention, whereas the screen-and-treat policy achieved 108 quality-adjusted life-years. Routine aspirin would result in an estimated cost saving of \u20ac14.9 million annually relative to no intervention, whereas screen-and-treat approach would result in a smaller cost saving of \u20ac3.1 million. When the analysis was extended to consider alternative screen-and-treat strategies, routine aspirin remained the optimally cost-effective approach. In conclusion, routine aspirin use in low-risk nulliparous women has a greater health gain and cost saving compared with both the Fetal Medicine Foundation and other screen-and-treat approaches.<\/jats:p>","DOI":"10.1161\/hypertensionaha.118.11718","type":"journal-article","created":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T08:51:41Z","timestamp":1539593501000},"page":"1391-1396","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":37,"title":["Preeclampsia Prevention Using Routine Versus Screening Test\u2013Indicated Aspirin in Low-Risk Women"],"prefix":"10.1161","volume":"72","author":[{"given":"Fionnuala","family":"Mone","sequence":"first","affiliation":[{"name":"From the UCD Perinatal Research Centre, National Maternity Hospital, Obstetrics and Gynaecology, School of Medicine, University College Dublin, Ireland (F.M., C.M., P.M., F.M.M.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F.","family":"O\u2019Mahony","sequence":"additional","affiliation":[{"name":"Centre for Health Policy and Management, School of Medicine, Trinity College Dublin, Ireland (J.F.O., E.T., C.N.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Tyrrell","sequence":"additional","affiliation":[{"name":"Centre for Health Policy and Management, School of Medicine, Trinity College Dublin, Ireland (J.F.O., E.T., C.N.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Mulcahy","sequence":"additional","affiliation":[{"name":"From the UCD Perinatal Research Centre, National Maternity Hospital, Obstetrics and Gynaecology, School of Medicine, University College Dublin, Ireland (F.M., C.M., P.M., F.M.M.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"McParland","sequence":"additional","affiliation":[{"name":"From the UCD Perinatal Research Centre, National Maternity Hospital, Obstetrics and Gynaecology, School of Medicine, University College Dublin, Ireland (F.M., C.M., P.M., F.M.M.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fionnuala","family":"Breathnach","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Royal College of Surgeons in Ireland, Rotunda Hospital, Dublin (F.B., P.D., E.T., F.D.M.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Morrison","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, National University of Ireland, Galway (J.J.M.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Higgins","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, University College Cork, Ireland (J.H.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Daly","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Coombe Women\u2019s and Infant\u2019s University Hospital, Dublin, Ireland (S.D.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Cotter","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Graduate Entry Medical School, University of Limerick, Ireland (A.C.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyson","family":"Hunter","sequence":"additional","affiliation":[{"name":"Department of Fetal Medicine, Royal Jubilee Maternity Hospital, Belfast, United Kingdom (A.H.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Dicker","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Royal College of Surgeons in Ireland, Rotunda Hospital, Dublin (F.B., P.D., E.T., F.D.M.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Tully","sequence":"additional","affiliation":[{"name":"Centre for Health Policy and Management, School of Medicine, Trinity College Dublin, Ireland (J.F.O., E.T., C.N.)"},{"name":"Department of Obstetrics and Gynaecology, Royal College of Surgeons in Ireland, Rotunda Hospital, Dublin (F.B., P.D., E.T., F.D.M.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fergal D.","family":"Malone","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Royal College of Surgeons in Ireland, Rotunda Hospital, Dublin (F.B., P.D., E.T., F.D.M.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Normand","sequence":"additional","affiliation":[{"name":"Centre for Health Policy and Management, School of Medicine, Trinity College Dublin, Ireland (J.F.O., E.T., C.N.)"},{"name":"Cicely Saunders Institute, King\u2019s College London, United Kingdom (C.N.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fionnuala M.","family":"McAuliffe","sequence":"additional","affiliation":[{"name":"From the UCD Perinatal Research Centre, National Maternity Hospital, Obstetrics and Gynaecology, School of Medicine, University College Dublin, Ireland (F.M., C.M., P.M., F.M.M.)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2016.09.076"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2015.08.034"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1704559"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/uog.17455"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2016.09.086"},{"key":"e_1_3_3_7_2","unstructured":"National Institute for Health and Clinical Excellence. NICE (2010) Guideline CG107: Hypertension in Pregnancy: The Management of Hypertensive Disorders During Pregnancy. https:\/\/www.nice.org.uk\/guidance\/cg107. Accessed September 5 2016."},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000437382.03963.88"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.7326\/M14-1884"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/ajo.12126"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2016.07.003"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-022056"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1159\/000341264"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.2012.01.110019"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.13914"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000001115"},{"key":"e_1_3_3_17_2","volume-title":"UK population norms for EQ-5D","author":"Kind P","year":"1999","unstructured":"Kind, P, Hardman, G, Macran, S. UK population norms for EQ-5D. York, United Kingdom: Centre for Health Economics, University of York; 1999."},{"key":"e_1_3_3_18_2","unstructured":"Central Statistics Office. Irish Life Tables 2010\u20132012. 2015. http:\/\/pdf.cso.ie\/www\/pdf\/20160219125015_Irish_Life_Tables_No_16_20102012_full.pdf. Accessed April 1 2017."},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-015-3824-0"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.3310\/hta12060"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/pd.2871"},{"key":"e_1_3_3_22_2","unstructured":"Central Statistics Office. Infant Mortality Stillbirths and Maternal Mortality 2017. http:\/\/www.cso.ie\/en\/releasesandpublications\/ep\/p-vsar\/vsar2014\/imsm\/. Accessed April 1 2017."},{"key":"e_1_3_3_23_2","unstructured":"Euro Foreign Exchange Rates. http:\/\/www.ecb.europa.eu\/stats\/policy_and_exchange_rates\/euro_reference_exchange_rates\/html\/index.en.html. Accessed May 30 2017."},{"key":"e_1_3_3_24_2","first-page":"CD004659","article-title":"Antiplatelet agents for preventing pre-eclamsia and its complications.","volume":"2","author":"Duley L","year":"2007","unstructured":"Duley, L, Henderson-Smart, DJ, Meher, S, King, JF. Antiplatelet agents for preventing pre-eclamsia and its complications. Cochrane Database Syst Rev. 2007;2:CD004659.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181e9322a"},{"key":"e_1_3_3_26_2","unstructured":"Health Information and Quality Authority. Guidelines for the Economic Evaluation of Health Technologies in Ireland. 2014. https:\/\/www.hiqa.ie\/sites\/default\/...\/Revised_Economic_Guidelines_posted_100714.pdf. Accessed April 1 2016."},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-015-0336-1"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X98018002S09"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.118.11718","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T09:58:11Z","timestamp":1715594291000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.118.11718"}},"subtitle":["A Cost-Effectiveness Analysis"],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.118.11718"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.118.11718","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"2018-06-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}